Ardelyx (ARDX) Gross Margin (2015 - 2026)

Ardelyx (ARDX) reported Gross Margin of 94.91% for Q1 2026, up 1151.0% on a YoY basis from 7.59% in Q1 2025, and up 3.91% quarter-over-quarter from 91.34% in Q4 2025.

Ardelyx (ARDX) Gross Margin (2015 - 2026) Analysis & Trends

Ardelyx has reported Gross Margin for 10 years, with the latest figure at 94.91% in Q1 2026.

  • For the quarter ending Q1 2026, Gross Margin rose 1151.0% year-over-year to 94.91%; the trailing twelve-month figure through Mar 2026 stood at 90.01% (up 542.0% YoY), and the FY2025 full-year result was 90.29%, up 545.0% from the prior year.
  • Gross Margin for Q1 2026 stood at 94.91%, up from 91.34% in the prior quarter.
  • The five-year high for Gross Margin was 94.91% in Q1 2026, with the low at 17.12% in Q3 2025.
  • Historically, Gross Margin has averaged 80.98% across 5 years, with a median of 85.32% in 2022.
  • Annual changes were most pronounced in 2025 — Gross Margin plunged 10111 bps — and 2026, when it surged 1151 bps.
  • Ardelyx's Gross Margin stood at 92.84% in 2022, then fell by 8 bps to 85.23% in 2023, then slipped by 1 bps to 84.27% in 2024, then increased by 8 bps to 91.34% in 2025, then rose by 4 bps to 94.91% in 2026.
  • The last three Gross Margin figures came in at 94.91% (Q1 2026), 91.34% (Q4 2025), and 17.12% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 79.04%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 86.85%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Ardelyx 1.49 Bn 1.25 Bn 89.66 Mn 94.91%

Historic Data

Download Data
DateValue
Mar 31, 2026 94.91%
Dec 31, 2025 91.34%
Sep 30, 2025 -17.12%
Jun 30, 2025 87.30%
Mar 31, 2025 83.40%
Dec 31, 2024 84.27%
Sep 30, 2024 83.99%
Jun 30, 2024 87.11%
Mar 31, 2024 84.51%
Dec 31, 2023 85.23%
Sep 30, 2023 86.36%
Jun 30, 2023 84.38%
Mar 31, 2023 86.48%
Dec 31, 2022 92.84%
Sep 30, 2022 85.32%
Jun 30, 2022 94.54%
Mar 31, 2022 81.84%
Dec 31, 2021 100.00%
Sep 30, 2021 100.00%
Jun 30, 2021 100.00%